Hot Products
Catalog No. | Information |
CFN70409 | Rhamnazin Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy, it attenuates inflammation and inhibits alkali burn-induced corneal neovascularization in rats. Rhamnazin has anti-oxidative, and anti-inflammatry activities, it also shows apoptogenic activity via mitochondrial pathway and associated with activation of caspase-9 and -3. |
CFN95116 | Rhamnetin 3-galactoside Reference standards. |
CFN97724 | Rhamnocitrin Rhamnocitrin can enhance the immune function, improve the formation of spleen cells of mice serum hemolysin of chicken red blood cell immune. Rhamnocitrin possesses significant anticataract activity and acts most likely due to its antioxidant property, it shows a significant protection against cloudiness in lenses induced by hydrogen peroxide and hydrocortisone in a dose dependent manner.Rhamnocitrin and kaempferol can augment cellular antioxidant defense capacity, at least in part, through regulation of HO-1 expression and MAPK signal transduction; they not only protect low-density lipoprotein from oxidation but also prevent atherogenesis through suppressing macrophage uptake of oxidized low-density lipoprotein. |
CFN95145 | Rhamnocitrin 3-apiosyl-(1->2)-glucoside Reference standards. |
CFN95134 | Rhamnocitrin 3-glucoside Reference standards. |
CFN98569 | Rhaponiticin Rhaponticin(Rhaponiticin) has a noticeable antidiabetic effect and could be potentially used as a new agent to treat type 2 diabetes mellitus and its complications, it can alleviate liver steatosis and improve blood glucose and lipid profiles in KK/Ay diabetic mice. |
CFN92607 | Rhapontigenin Rhapontigenin has antioxidative, antihyperlipidemic, antifungal and anticancer activities. Rhapontigenin inhibits HIF-1α accumulation and angiogenesis in PC-3 prostate cancer cells, suppresses breast cancer cell migration and invasion, which is involved in inhibiting the PI3K-dependent Rac1 signaling pathway. Rhapontigenin exhibits dose-dependent inhibition of tyrosinase activity and melanin synthesis in B16F10 melanoma cells. |
CFN90749 | Rhapontigenin 3'-O-glucoside Reference standards. |
CFN90522 | Rhapontisterone B Reference standards. |
CFN99157 | Rhein Rhein has many pharmacological effects, including epatoprotective, nephroprotective, anti-inflammatory, antioxidant, anticancer, and antimicrobial activities, it has been proved effective in treatment of experimental diabetic nephropathy , one of the mechanism is the Inhibition of the hexosamine pathway. Rhein has protective effect on liver injury, the mechanisms possibly contribute to its action of antioxidant and anti-inflammatory activity, also associated with its effect of inhibiting TGF-β1 and suppressing the activation of hepatic stellate cells. |